Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial

Saved in:
Bibliographic Details
Published in:Journal of the American Academy of Dermatology 2014-03, Vol.70 (3), p.583-584
Main Authors: Okon, Lauren, MD, Rosenbach, Misha, MD, Krathen, Michael, MD, Rose, Mathew, MS, Propert, Kathleen, ScD, Okawa, Joyce, RN, Werth, Victoria, MD
Format: Article
Language:English
Subjects:
Administration, Oral
Biopsy, Needle
Dermatology
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Immunohistochemistry
Lupus Erythematosus, Cutaneous - drug therapy
Lupus Erythematosus, Cutaneous - pathology
Male
Patient Safety
Prospective Studies
Severity of Illness Index
Thalidomide - analogs & derivatives
Thalidomide - therapeutic use
Time Factors
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0190-9622
1097-6787
DOI:10.1016/j.jaad.2013.11.007